Rita A. Karachun - May 2, 2023 Form 4 Insider Report for Merck & Co., Inc. (MRK)

Role
Sr. VP Fince-Global Controller
Signature
/s/ Kelly E. W. Grez as Attorney-in-Fact for Rita Karachun
Stock symbol
MRK
Transactions as of
May 2, 2023
Transactions value $
$0
Form type
4
Date filed
5/4/2023, 06:33 PM
Previous filing
May 3, 2023
Next filing
May 5, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Ownership Footnotes
holding MRK Common Stock 44.6K May 2, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRK Stock Option (Right to Buy) Award $0 +9.68K $0.00 9.68K May 2, 2023 Common Stock 9.68K $117.89 Direct F1
transaction MRK Restricted Stock Unit Award $0 +1.78K $0.00 1.78K May 2, 2023 Common Stock 1.78K Direct F2, F3

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable in equal installments on 5/2/2024, 5/2/2025 and 5/2/2026.
F2 Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
F3 These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/2/2024, 5/2/2025 and 5/2/2026.